Www.pbm.va.gov

12% rate of positive ANA compared with 7% placebo. 1 patient out of 2334 developed signs and symptoms of new-onset lupus-like syndrome that improved upon discontinuation of therapy. In patients with RA treated with certolizumab, 4 of 2367 patients developed signs suggestive of lupus-like syndrome. ................
................